-
1
-
-
0031753867
-
Gene transfer into muscle by electroporation in vivo
-
Aihara H, Miyazaki J (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16(9):867-870
-
(1998)
Nat Biotechnol
, vol.16
, Issue.9
, pp. 867-870
-
-
Aihara, H.1
Miyazaki, J.2
-
2
-
-
14744268262
-
CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2
-
Antony PA, Restifo NP (2005) CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28(2):120-128
-
(2005)
J Immunother
, vol.28
, Issue.2
, pp. 120-128
-
-
Antony, P.A.1
Restifo, N.P.2
-
3
-
-
0036005892
-
GM-CSF-based cellular vaccines: A review of the clinical experience
-
Borrello I, Pardoll D (2002) GM-CSF-based cellular vaccines: a review of the clinical experience. Cytokine Growth Factor Rev 13(2):185-193
-
(2002)
Cytokine Growth Factor Rev
, vol.13
, Issue.2
, pp. 185-193
-
-
Borrello, I.1
Pardoll, D.2
-
4
-
-
0344153890
-
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
-
Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, Prieto J, Borras-Cuesta F, Lasarte JJ (2003) CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 171(11):5931-5939
-
(2003)
J Immunol
, vol.171
, Issue.11
, pp. 5931-5939
-
-
Casares, N.1
Arribillaga, L.2
Sarobe, P.3
Dotor, J.4
Lopez-Diaz De Cerio, A.5
Melero, I.6
Prieto, J.7
Borras-Cuesta, F.8
Lasarte, J.J.9
-
5
-
-
0027078670
-
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
-
Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71(7):1093-1102
-
(1992)
Cell
, vol.71
, Issue.7
, pp. 1093-1102
-
-
Chen, L.1
Ashe, S.2
Brady, W.A.3
Hellstrom, I.4
Hellstrom, K.E.5
Ledbetter, J.A.6
McGowan, P.7
Linsley, P.S.8
-
6
-
-
0027982995
-
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity
-
Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellstrom I, Hellstrom KE (1994) Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med 179(2):523-532
-
(1994)
J Exp Med
, vol.179
, Issue.2
, pp. 523-532
-
-
Chen, L.1
McGowan, P.2
Ashe, S.3
Johnston, J.4
Li, Y.5
Hellstrom, I.6
Hellstrom, K.E.7
-
7
-
-
0027946018
-
B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum
-
Chen L, McGowan P, Ashe S, Johnston JV, Hellstrom I, Hellstrom KE (1994) B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res 54(20):5420-5423
-
(1994)
Cancer Res
, vol.54
, Issue.20
, pp. 5420-5423
-
-
Chen, L.1
McGowan, P.2
Ashe, S.3
Johnston, J.V.4
Hellstrom, I.5
Hellstrom, K.E.6
-
8
-
-
28944452245
-
Development of a whole cell vaccine for acute myeloid leukaemia
-
Cheuk AT, Chan L, Czepulkowski B, Berger SA, Yagita H, Okumura K, Farzaneh F, Mufti GJ, Guinn BA (2006) Development of a whole cell vaccine for acute myeloid leukaemia. Cancer Immunol Immunother 55(1):68-75
-
(2006)
Cancer Immunol Immunother
, vol.55
, Issue.1
, pp. 68-75
-
-
Cheuk, A.T.1
Chan, L.2
Czepulkowski, B.3
Berger, S.A.4
Yagita, H.5
Okumura, K.6
Farzaneh, F.7
Mufti, G.J.8
Guinn, B.A.9
-
9
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942-949
-
(2004)
Nat Med
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
10
-
-
30144444279
-
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
-
Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D, Zhang A, Dahm P, Chao N, Gilboa E, Vieweg J (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115(12):3623-3633
-
(2005)
J Clin Invest
, vol.115
, Issue.12
, pp. 3623-3633
-
-
Dannull, J.1
Su, Z.2
Rizzieri, D.3
Yang, B.K.4
Coleman, D.5
Yancey, D.6
Zhang, A.7
Dahm, P.8
Chao, N.9
Gilboa, E.10
Vieweg, J.11
-
11
-
-
1642546952
-
Enhancing CTL responses to melanoma cell vaccines in vivo: Synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells
-
Dezfouli S, Hatzinisiriou I, Ralph SJ (2003) Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells. Immunol Cell Biol 81(6):459-471
-
(2003)
Immunol Cell Biol
, vol.81
, Issue.6
, pp. 459-471
-
-
Dezfouli, S.1
Hatzinisiriou, I.2
Ralph, S.J.3
-
12
-
-
0027538181
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
-
USA
-
Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90(8):3539-3543
-
(1993)
Proc Natl Acad Sci
, vol.90
, Issue.8
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
Golumbek, P.4
Levitsky, H.5
Brose, K.6
Jackson, V.7
Hamada, H.8
Pardoll, D.9
Mulligan, R.C.10
-
13
-
-
0033586324
-
Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models
-
Emtage PC, Wan Y, Hitt M, Graham FL, Muller WJ, Zlotnik A, Gauldie J (1999) Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther 10(5):697-709
-
(1999)
Hum Gene Ther
, vol.10
, Issue.5
, pp. 697-709
-
-
Emtage, P.C.1
Wan, Y.2
Hitt, M.3
Graham, F.L.4
Muller, W.J.5
Zlotnik, A.6
Gauldie, J.7
-
14
-
-
2342501737
-
CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells
-
Hayball JD, Robinson BW, Lake RA (2004) CD4+ T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells. Immunol Cell Biol 82(2):103-111
-
(2004)
Immunol Cell Biol
, vol.82
, Issue.2
, pp. 103-111
-
-
Hayball, J.D.1
Robinson, B.W.2
Lake, R.A.3
-
15
-
-
0034536936
-
In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity
-
Heller L, Pottinger C, Jaroszeski MJ, Gilbert R, Heller R (2000) In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res 10(6):577-583
-
(2000)
Melanoma Res
, vol.10
, Issue.6
, pp. 577-583
-
-
Heller, L.1
Pottinger, C.2
Jaroszeski, M.J.3
Gilbert, R.4
Heller, R.5
-
16
-
-
30344481357
-
Oral immune tolerance mediated by suppressor T cells may be responsible for the poorer prognosis of foregut cancers
-
Larkin J, Tangney M, Collins C, Casey G, O'Brien MG, Soden D, O'Sullivan GC (2006) Oral immune tolerance mediated by suppressor T cells may be responsible for the poorer prognosis of foregut cancers. Med Hypotheses 66(3):541-544
-
(2006)
Med Hypotheses
, vol.66
, Issue.3
, pp. 541-544
-
-
Larkin, J.1
Tangney, M.2
Collins, C.3
Casey, G.4
O'Brien, M.G.5
Soden, D.6
O'Sullivan, G.C.7
-
17
-
-
0027403299
-
The role of the CD28 receptor during T cell responses to antigen
-
Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191-212
-
(1993)
Annu Rev Immunol
, vol.11
, pp. 191-212
-
-
Linsley, P.S.1
Ledbetter, J.A.2
-
18
-
-
0025322552
-
T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1
-
USA
-
Linsley PS, Clark EA, Ledbetter JA (1990) T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 87(13):5031-5035
-
(1990)
Proc Natl Acad Sci
, vol.87
, Issue.13
, pp. 5031-5035
-
-
Linsley, P.S.1
Clark, E.A.2
Ledbetter, J.A.3
-
19
-
-
0025219689
-
Dormancy and breast cancer
-
Meltzer A (1990) Dormancy and breast cancer. J Surg Oncol 43(3):181-188
-
(1990)
J Surg Oncol
, vol.43
, Issue.3
, pp. 181-188
-
-
Meltzer, A.1
-
20
-
-
30744448160
-
T cells targeted against a single minor histocompatibility antigen can cure solid tumors
-
Meunier MC, Delisle JS, Bergeron J, Rineau V, Baron C, Perreault C (2005) T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med 11(11):1222-1229
-
(2005)
Nat Med
, vol.11
, Issue.11
, pp. 1222-1229
-
-
Meunier, M.C.1
Delisle, J.S.2
Bergeron, J.3
Rineau, V.4
Baron, C.5
Perreault, C.6
-
21
-
-
0035985655
-
Cancer vaccines, a critical review - Part I
-
Mitchell MS (2002) Cancer vaccines, a critical review - Part I. Curr Opin Investig Drugs 3(1):140-149
-
(2002)
Curr Opin Investig Drugs
, vol.3
, Issue.1
, pp. 140-149
-
-
Mitchell, M.S.1
-
22
-
-
0032401860
-
EblacZ tumor dormancy in bone marrow and lymph nodes: Active control of proliferating tumor cells by CD8+ immune T cells
-
Muller M, Gounari F, Prifti S, Hacker HJ, Schirrmacher V, Khazaie K (1998) EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res 58(23):5439-5446
-
(1998)
Cancer Res
, vol.58
, Issue.23
, pp. 5439-5446
-
-
Muller, M.1
Gounari, F.2
Prifti, S.3
Hacker, H.J.4
Schirrmacher, V.5
Khazaie, K.6
-
23
-
-
0037172969
-
CD25+CD4+ T cells contribute to the control of memory CD8+ T cells
-
USA
-
Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P (2002) CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci USA 99(13):8832-8837
-
(2002)
Proc Natl Acad Sci
, vol.99
, Issue.13
, pp. 8832-8837
-
-
Murakami, M.1
Sakamoto, A.2
Bender, J.3
Kappler, J.4
Marrack, P.5
-
24
-
-
0033638189
-
The inflammatory response within Dukes' B colorectal cancers: Implications for progression of micrometastases and patient survival
-
Murphy J, O'Sullivan GC, Lee G, Madden M, Shanahan F, Collins JK, Talbot IC (2000) The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival. Am J Gastroenterol 95(12):3607-3614
-
(2000)
Am J Gastroenterol
, vol.95
, Issue.12
, pp. 3607-3614
-
-
Murphy, J.1
O'Sullivan, G.C.2
Lee, G.3
Madden, M.4
Shanahan, F.5
Collins, J.K.6
Talbot, I.C.7
-
25
-
-
0032996037
-
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: Suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
-
Nasu Y, Bangma CH, Hull GW, Lee HM, Hu J, Wang J, McCurdy MA, Shimura S, Yang G, Timme TL, Thompson TC (1999) Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther 6(3):338-349
-
(1999)
Gene Ther
, vol.6
, Issue.3
, pp. 338-349
-
-
Nasu, Y.1
Bangma, C.H.2
Hull, G.W.3
Lee, H.M.4
Hu, J.5
Wang, J.6
McCurdy, M.A.7
Shimura, S.8
Yang, G.9
Timme, T.L.10
Thompson, T.C.11
-
26
-
-
10744229445
-
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer
-
Nemunaitis J, Sterman D, Jablons D, Smith JW II, Fox B, Maples P, Hamilton S, Borellini F, Lin A, Morali S, Hege K (2004) Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer. J Natl Cancer Inst 96(4):326-331
-
(2004)
J Natl Cancer Inst
, vol.96
, Issue.4
, pp. 326-331
-
-
Nemunaitis, J.1
Sterman, D.2
Jablons, D.3
Smith II, J.W.4
Fox, B.5
Maples, P.6
Hamilton, S.7
Borellini, F.8
Lin, A.9
Morali, S.10
Hege, K.11
-
27
-
-
0020339802
-
Gene transfer into mouse lyoma cells by electroporation in high electric fields
-
Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo J 1(7):841-845
-
(1982)
Embo J
, vol.1
, Issue.7
, pp. 841-845
-
-
Neumann, E.1
Schaefer-Ridder, M.2
Wang, Y.3
Hofschneider, P.H.4
-
28
-
-
0033018370
-
The Fas counterattack: Cancer as a site of immune privilege
-
O'Connell J (1999) The Fas counterattack: cancer as a site of immune privilege. Immunol Today 20(1):46-52
-
(1999)
Immunol Today
, vol.20
, Issue.1
, pp. 46-52
-
-
O'Connell, J.1
-
29
-
-
0029808372
-
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
-
O'Connell J, O'Sullivan GC, Collins JK, Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184(3):1075-1082
-
(1996)
J Exp Med
, vol.184
, Issue.3
, pp. 1075-1082
-
-
O'Connell, J.1
O'Sullivan, G.C.2
Collins, J.K.3
Shanahan, F.4
-
30
-
-
0028835165
-
Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer
-
O'Sullivan GC, Collins JK, O'Brien F, Crowley B, Murphy K, Lee G, Shanahan F (1995) Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. Gastroenterology 109(5):1535-1540
-
(1995)
Gastroenterology
, vol.109
, Issue.5
, pp. 1535-1540
-
-
O'Sullivan, G.C.1
Collins, J.K.2
O'Brien, F.3
Crowley, B.4
Murphy, K.5
Lee, G.6
Shanahan, F.7
-
31
-
-
0030588698
-
Regional immunosuppression in esophageal squamous cancer: Evidence from functional studies with matched lymph nodes
-
O'Sullivan GC, Corbett AR, Shanahan F, Collins JK (1996) Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes. J Immunol 157(10):4717-4720
-
(1996)
J Immunol
, vol.157
, Issue.10
, pp. 4717-4720
-
-
O'Sullivan, G.C.1
Corbett, A.R.2
Shanahan, F.3
Collins, J.K.4
-
32
-
-
0031011135
-
Micrometastases: Marker of metastatic potential or evidence of residual disease?
-
O'Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F (1997) Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 40(4):512-515
-
(1997)
Gut
, vol.40
, Issue.4
, pp. 512-515
-
-
O'Sullivan, G.C.1
Collins, J.K.2
Kelly, J.3
Morgan, J.4
Madden, M.5
Shanahan, F.6
-
33
-
-
0033011433
-
Micrometastases in esophagogastric cancer: High detection rate in resected rib segments
-
O'Sullivan GC, Sheehan D, Clarke A, Stuart R, Kelly J, Kiely MD, Walsh T, Collins JK, Shanahan F (1999) Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology 116(3):543-548
-
(1999)
Gastroenterology
, vol.116
, Issue.3
, pp. 543-548
-
-
O'Sullivan, G.C.1
Sheehan, D.2
Clarke, A.3
Stuart, R.4
Kelly, J.5
Kiely, M.D.6
Walsh, T.7
Collins, J.K.8
Shanahan, F.9
-
34
-
-
0033168037
-
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody
-
Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59(13):3128-3133
-
(1999)
Cancer Res
, vol.59
, Issue.13
, pp. 3128-3133
-
-
Onizuka, S.1
Tawara, I.2
Shimizu, J.3
Sakaguchi, S.4
Fujita, T.5
Nakayama, E.6
-
35
-
-
29144514645
-
Effector memory T cells, early metastasis, and survival in colorectal cancer
-
Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654-2666
-
(2005)
N Engl J Med
, vol.353
, Issue.25
, pp. 2654-2666
-
-
Pages, F.1
Berger, A.2
Camus, M.3
Sanchez-Cabo, F.4
Costes, A.5
Molidor, R.6
Mlecnik, B.7
Kirilovsky, A.8
Nilsson, M.9
Damotte, D.10
Meatchi, T.11
Bruneval, P.12
Cugnenc, P.H.13
Trajanoski, Z.14
Fridman, W.H.15
Galon, J.16
-
37
-
-
0028343870
-
T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells
-
Ramarathinam L, Castle M, Wu Y, Liu Y (1994) T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med 179(4):1205-1214
-
(1994)
J Exp Med
, vol.179
, Issue.4
, pp. 1205-1214
-
-
Ramarathinam, L.1
Castle, M.2
Wu, Y.3
Liu, Y.4
-
38
-
-
0034670157
-
The role of CpG motifs in immunostimulation and gene therapy
-
Scheule RK (2000) The role of CpG motifs in immunostimulation and gene therapy. Adv Drug Deliv Rev 44(2-3):119-134
-
(2000)
Adv Drug Deliv Rev
, vol.44
, Issue.2-3
, pp. 119-134
-
-
Scheule, R.K.1
-
39
-
-
0036597371
-
CD4+ CD25+ suppressor T cells: More questions than answers
-
Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2(6):389-400
-
(2002)
Nat Rev Immunol
, vol.2
, Issue.6
, pp. 389-400
-
-
Shevach, E.M.1
-
40
-
-
0033571105
-
Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity
-
Shimizu J, Yamazaki S, Sakaguchi S. (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163(10):5211-5218
-
(1999)
J Immunol
, vol.163
, Issue.10
, pp. 5211-5218
-
-
Shimizu, J.1
Yamazaki, S.2
Sakaguchi, S.3
-
41
-
-
31644451104
-
Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours
-
Soden DM, Larkin JO, Collins CG, Tangney M, Aarons S, Piggott J, Morrissey A, Dunne C, O'Sullivan GC (2005) Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett 232(2):300-310
-
(2005)
Cancer Lett
, vol.232
, Issue.2
, pp. 300-310
-
-
Soden, D.M.1
Larkin, J.O.2
Collins, C.G.3
Tangney, M.4
Aarons, S.5
Piggott, J.6
Morrissey, A.7
Dunne, C.8
O'Sullivan, G.C.9
-
42
-
-
0035893387
-
Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T cell-dependent immune defense of B16 melanoma
-
Steitz J, Bruck J, Lenz J, Knop J, Tuting T (2001) Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T cell-dependent immune defense of B16 melanoma. Cancer Res 61(24):8643-8646
-
(2001)
Cancer Res
, vol.61
, Issue.24
, pp. 8643-8646
-
-
Steitz, J.1
Bruck, J.2
Lenz, J.3
Knop, J.4
Tuting, T.5
-
43
-
-
0032503016
-
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine
-
Thomas MC, Greten TF, Pardoll DM, Jaffee EM (1998) Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine. Hum Gene Ther 9(6):835-843
-
(1998)
Hum Gene Ther
, vol.9
, Issue.6
, pp. 835-843
-
-
Thomas, M.C.1
Greten, T.F.2
Pardoll, D.M.3
Jaffee, E.M.4
-
44
-
-
0028646191
-
Specificity and longevity of antitumor immune responses induced by B7-transfected tumors
-
Townsend SE, Su FW, Atherton JM, Allison JP (1994) Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 54(24):6477-6483
-
(1994)
Cancer Res
, vol.54
, Issue.24
, pp. 6477-6483
-
-
Townsend, S.E.1
Su, F.W.2
Atherton, J.M.3
Allison, J.P.4
-
46
-
-
1642497640
-
Tumor-specific human CD4+ regulatory T cells and their ligands: Implications for immunotherapy
-
Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF (2004) Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20(1):107-118
-
(2004)
Immunity
, vol.20
, Issue.1
, pp. 107-118
-
-
Wang, H.Y.1
Lee, D.A.2
Peng, G.3
Guo, Z.4
Li, Y.5
Kiniwa, Y.6
Shevach, E.M.7
Wang, R.F.8
-
47
-
-
0742321751
-
Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells
-
Wei WZ, Morris GP, Kong YC (2004) Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53(2):73-78
-
(2004)
Cancer Immunol Immunother
, vol.53
, Issue.2
, pp. 73-78
-
-
Wei, W.Z.1
Morris, G.P.2
Kong, Y.C.3
-
48
-
-
15444377017
-
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
-
Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201(5):779-791
-
(2005)
J Exp Med
, vol.201
, Issue.5
, pp. 779-791
-
-
Yu, P.1
Lee, Y.2
Liu, W.3
Krausz, T.4
Chong, A.5
Schreiber, H.6
Fu, Y.X.7
-
49
-
-
16844379997
-
Immunosuppressive networks in the tumour environment and their therapeutic relevance
-
Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5(4):263-274
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.4
, pp. 263-274
-
-
Zou, W.1
|